| |
|
|
|
Glaucoma: Cause
Description: Glaucoma affects about 70 million people worldwide, over 6.7 million of whom are bilaterally blind. As the American population ages, the risk of developing glaucoma is rapidly increasing. Glaucoma is projected to affect 3.4 million people by the year 2020.
All glaucomas, whether narrow angle, open angle, or associated with systemic or ocular disease, are progressive optic neuropathies. This course discuses the epidemiology of the major types of glaucoma; the pathophysiology of open angle glaucomas without other known ocular or systemic disorders; angle closure glaucomas without other known ocular or systemic disorders; developmental or congenital glaucomas; and glaucomas associated with other ocular and systemic disorders (disorders of the retina, choroid, or vitreous; intraocular tumors; inflammation; steroid-induced disorders; trauma; hemorrhage; iatrogenic disorders; and postoperative disorders).
|
COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview
SYSTEM OVERVIEW
4. Objectives
5. Aqueous Production and Flow
6. Progress Check
PATHOPHYSIOLOGY
7. Objectives
8. Acute Angle Closure
9. Open Angle Glaucoma
10. Uveitic Glaucoma
11. Pigmentary Glaucoma
12. Plateau Iris
13. Pseudoexfoliation Glaucoma
14. Phacomorphic Glaucoma
15. Neovascular Glaucoma
16. Steroid-Induced Glaucoma
17. Progress Check
EPIDEMIOLOGY
18. Objectives
19. Epidemiology of Acute Angle Closure
20. Epidemiology of Open Angle Glaucoma
21. Progress Check
CONCLUSION
22. Summary
GLOSSARY/RESOURCES
|
|
COURSE OBJECTIVES
Students completing this course should be able
to:
- Review the normal physiology of the aqueous production
- Explain the origin of acute angle closure
- Identify normal patterns of aqueous flow
- Describe the mechanism of acute angle closure
- Describe theories of optic nerve damage in open angle glaucoma
- Name the cells that sustain damage in glaucoma
- Describe inflammatory glaucomas and identify diseases that predispose to uveitic or inflammatory glaucoma
- Describe the prevalence of angle closure and open angle glaucoma
- Discuss the epidemiology of angle closure and open angle glaucoma
- Identify risk factors associated with narrow angle and open angle glaucoma
|
|
|
|
 SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.
|
|
